Company news

CelLBxHealth plc news in 2018

CelLBxHealth plc's news releases, calls and decks from 2018, newest first.

View company

Leading US hematopathologist appointed as advisor

November 28, 2018

Acquisition of outstanding shares

November 5, 2018

Appointment of Dr Jan Groen as NED

November 1, 2018

Parsortix shows capability to harvest fetal cells

October 29, 2018

Good Progress with FDA Studies

October 25, 2018

Parsortix shows evidence of CTCs in glioblastoma

August 28, 2018

Preliminary Results for year ended 30 April 2018

July 25, 2018

EIS/VCT Advance Assurance and Total Voting Rights

July 24, 2018

Notice of Preliminary Results

July 2, 2018

Results of Fundraising

June 25, 2018

Encouraging progress in ANG-002 FDA clinical study

June 4, 2018

Leading cancer surgeon appointed

May 14, 2018

Angle & QIAGEN Poster

May 3, 2018

Parsortix in multiple presentations at AACR

April 19, 2018

First patient enrolled in FDA study

April 5, 2018

Research Update

March 26, 2018

ANGLE plc: RESEARCH GRANT FROM ABBOTT

February 6, 2018

Webinar: using parsortix to test drugs on live CTCs

January 16, 2018

ANGLE plc: Prostate cancer ARV7 treatment biomarker

January 8, 2018

Decks in 2018